Montay G - Search Results

1

Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance.

Baille P, Bruno R, Schellens JH, Webster LK, Millward M, Verweij J, Montay G. Baille P, et al. Among authors: montay g. Clin Cancer Res. 1997 Sep;3(9):1535-8. Clin Cancer Res. 1997. PMID: 9815840 Clinical Trial.

2

Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic method.

Vergniol JC, Bruno R, Montay G, Frydman A. Vergniol JC, et al. Among authors: montay g. J Chromatogr. 1992 Nov 6;582(1-2):273-8. doi: 10.1016/0378-4347(92)80333-l. J Chromatogr. 1992. PMID: 1362729

3

A population pharmacokinetic model for docetaxel (Taxotere): model building and validation.

Bruno R, Vivier N, Vergniol JC, De Phillips SL, Montay G, Sheiner LB. Bruno R, et al. Among authors: montay g. J Pharmacokinet Biopharm. 1996 Apr;24(2):153-72. doi: 10.1007/BF02353487. J Pharmacokinet Biopharm. 1996. PMID: 8875345 Clinical Trial.

4

Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships for docetaxel.

Bruno R, Vivier N, Veyrat-Follet C, Montay G, Rhodes GR. Bruno R, et al. Among authors: montay g. Invest New Drugs. 2001 May;19(2):163-9. doi: 10.1023/a:1010687017717. Invest New Drugs. 2001. PMID: 11392450 Review.

5

Evaluation of Bayesian estimation in comparison to NONMEM for population pharmacokinetic data analysis: application to pefloxacin in intensive care unit patients.

Bruno R, Iliadis MC, Lacarelle B, Cosson V, Mandema JW, Le Roux Y, Montay G, Durand A, Ballereau M, Alasia M, et al. Bruno R, et al. Among authors: montay g. J Pharmacokinet Biopharm. 1992 Dec;20(6):653-69. doi: 10.1007/BF01064424. J Pharmacokinet Biopharm. 1992. PMID: 1302767

6

Evaluation of Bayesian estimation to discriminate subpopulations of patients with altered pharmacokinetics using fragmentary data: a pilot study with pefloxacin.

Bruno R, Rosier P, Iliadis A, Le Roux Y, Montay G, Frydman A, Gaillot J. Bruno R, et al. Among authors: montay g. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:338-45. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1820906

7

Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis.

Bruno R, Vivier N, Montay G, Le Liboux A, Powe LK, Delumeau JC, Rhodes GR. Bruno R, et al. Among authors: montay g. Clin Pharmacol Ther. 1997 Nov;62(5):518-26. doi: 10.1016/S0009-9236(97)90047-3. Clin Pharmacol Ther. 1997. PMID: 9390108

8

Pharmacokinetics of sparfloxacin in humans after single oral administration at doses of 200, 400, 600, and 800 mg.

Montay G, Bruno R, Vergniol JC, Ebmeier M, Le Roux Y, Guimart C, Frydman A, Chassard D, Thebault JJ. Montay G, et al. J Clin Pharmacol. 1994 Nov;34(11):1071-6. doi: 10.1002/j.1552-4604.1994.tb01983.x. J Clin Pharmacol. 1994. PMID: 7876398 Clinical Trial.

9

Pharmacokinetics of sparfloxacin in patients with renal impairment.

Fillastre JP, Montay G, Bruno R, Etienne I, Dhib M, Vivier N, Le Roux Y, Guimart C, Gay G, Schott D. Fillastre JP, et al. Among authors: montay g. Antimicrob Agents Chemother. 1994 Apr;38(4):733-7. doi: 10.1128/AAC.38.4.733. Antimicrob Agents Chemother. 1994. PMID: 8031038 Free PMC article.

10

Single- and multiple-dose pharmacokinetics of riluzole in white subjects.

Le Liboux A, Lefebvre P, Le Roux Y, Truffinet P, Aubeneau M, Kirkesseli S, Montay G. Le Liboux A, et al. Among authors: montay g. J Clin Pharmacol. 1997 Sep;37(9):820-7. doi: 10.1002/j.1552-4604.1997.tb05630.x. J Clin Pharmacol. 1997. PMID: 9549636 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters